Citigroup »

Affimed Therapeutics B V shares owned by Citigroup

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $77 122 0.64
2023-09-30 $1.0k 2.1k 0.48
2023-03-31 $1.3k 1.8k 0.75
2022-12-31 $3.7k 3.0k 1.24
2022-09-30 $8.0k 4.1k 1.97
2021-12-31 $183k 33k 5.52
2021-03-31 $76k 9.7k 7.87
2020-12-31 $109k 19k 5.82
2020-09-30 $30k 8.9k 3.38
2020-06-30 $68k 15k 4.61
2020-03-31 $41k 26k 1.58
2019-12-31 $57k 21k 2.76
2019-09-30 $8.3k 2.9k 2.84
2019-06-30 $48k 17k 2.90
2016-09-30 $15k 5.4k 2.80
2016-06-30 $11k 4.2k 2.52
2015-12-31 $24k 3.5k 7.04
2015-09-30 $4.0k 689 5.81
2015-06-30 $3.0k 199 15.08